Lifecome BiochemistryLtd Balance Sheet Health
Financial Health criteria checks 2/6
Lifecome BiochemistryLtd has a total shareholder equity of CN¥328.4M and total debt of CN¥946.8M, which brings its debt-to-equity ratio to 288.3%. Its total assets and total liabilities are CN¥1.8B and CN¥1.4B respectively.
Key information
288.3%
Debt to equity ratio
CN¥946.85m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥31.59m |
| Equity | CN¥328.44m |
| Total liabilities | CN¥1.44b |
| Total assets | CN¥1.77b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002868's short term assets (CN¥303.0M) do not cover its short term liabilities (CN¥812.3M).
Long Term Liabilities: 002868's short term assets (CN¥303.0M) do not cover its long term liabilities (CN¥625.4M).
Debt to Equity History and Analysis
Debt Level: 002868's net debt to equity ratio (278.7%) is considered high.
Reducing Debt: 002868's debt to equity ratio has increased from 4.8% to 288.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 002868 has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 002868 is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.